CONNAUGHTON BERNADETTE sold 1.9% of their position (829.00 shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $59.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/1/2025ACC: 0001159036-25-000065
Director
Since Sep 2018
-829.00
Net shares
Net seller
$59.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
829.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−829.00
Price / share
$71.60
Trade value
$59.36K
% of position
1.9%
12/1/2025
42.95K→42.12K
Total
Net shares
−829.00
Net value
-$59.36K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/1/2025 | S · Sale | −829.00 | $71.60 | $59.36K | 1.9% | 42.95K | 42.12K |
| Total | −829.00 | -$59.36K | ||||||
Derivative Transactions0
No derivative transactions reported